A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease
Clinical trial NCT06001177 · COMPLETED
Trial details
- NCT number
- NCT06001177
- Sponsor
- Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-13
- Primary completion
- 2025-01-03
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.